Intellia Therapeutics, Inc. (NTLA): 8-K filed Aug 6, 2026

Form type

8-K

Filing date

Aug 6, 2026

Accession number

0001193125-26-336772

Filer

Intellia Therapeutics, Inc. (CIK 1652130)